RHD PCR of D-negative blood donors

Transfusion Medicine and Hemotherapy

Volumn 40, Issue 3, 2013, Pages 172-181

  Wagner, Franz F ^a  

^a DRK Blutspendedienst NSTOB   (Germany)

Author keywords

Antigen D; Blood donors; DEL; Indirect antiglobulin test; Rh blood group; RHD PCR; Weak D

Indexed keywords

BLOOD GROUP ANTIGEN; RHESUS D ANTIBODY; VACCINE; RHESUS D ANTIGEN;

ALLELE; ASIAN; BLOOD DONOR; CHIMERA; COOMBS TEST; COST EFFECTIVENESS ANALYSIS; DONOR SELECTION; EUROPE; HUMAN; IMMUNOGENICITY; NONHUMAN; PHENOTYPE; POLYMERASE CHAIN REACTION; REVIEW; RHESUS IMMUNIZATION; ALLOIMMUNIZATION; ERYTHROCYTE;

EID: 84879403175     PISSN: 16603796     EISSN: 16603818     Source Type: Journal    
DOI: 10.1159/000351604     Document Type: Review

References (58)

1. Cohn Y, Chérif-Zahar B, Le Van Kim C, Raynal V, Van Huffel V, Cartron JP: Genetic basis of the RhD-positive and RhD-negative blood group polymorphism as determined by Southern analysis. Blood 1991;78: 2747 - 2752.
2. Le van Kim C, Mouro I, Chérif-Zahar B, Raynal V, Cherrier C, Cartron JP, Cohn Y: Molecular cloning and primary structure of the human blood group RhD polypeptide. Proc NatI Acad Sci USA. 1992;89: 10925 - 10929.
3. Arce MA, Thompson ES, Wagner S, Coyne KE, Ferdman BA, Lublin DM: Molecular cloning of RhD cDNA derived from a gene present in RhD-positive, but not RhD-negative individuals. Blnnd 1993:22:651 - 655.
4. Bennett PR, Le Van Kim C, Cohn Y, Warwick RM, Chérif-Zahar B, Fisk NM, Cartron JP: Prenatal determination of fetal RhD type by DNA amplification. N EngI J Med 1993;329:607 - 610.
5. Daniels G, Green C, Smart E: Differences between RhD-negative Africans and RhD-negative Europeans. Lancet 1997;350:862 - 863.
6. Okuda H, Kawano M, Iwamoto S, Tanaka M, Seno T, Okubo Y, Kajii E: The RHD gene is highly detectable in RhD-negative Japanese donors. J Chin Invest 1997; 100:373 - 379.
7. Avent ND, Martin PG, Armstrong-Fisher SS, Liu W, Finning KM, Maddocks D,Urbaniak SJ: Evidence of genetic diversity underlying Rh D-, weak D (Du), and partial D phenotypes as determined by multiplex pohymerase chain reaction analysis of the RHD gene. Blood 1997;89:2568 - 2577.
8. Wagner FF, Frohmajer A, Flegel WA: RHD positive haphotypes in D negative Europeans. BMC Genet 2001;2:10.
9. Krog GR, Chausen FB, Berkowicz A, Jørgensen L, Rieneck K, Nielsen LK, Dziegieh MH: Is current serologic RhD typing of blood donors sufficient for avoiding immunization of recipients? Transfusion 2011:51:2278 - 2285.
10. Frohn C, Dumbgen L Brand TM, Görg S, Luhm J, Kirchner H: Probability of anti-D development in Dpatients receiving D+ RBCs. Transfusion 2003;43: 893 - 898.
11. Yazer MH, Triuhzi DJ: Detection of anti-D in D- recipients transfused with D+ red blood cells. Transfusion 2007;47:2197 - 2201.
12. Gonzahez-Porras JR, Graciani IF, Perez-Simon TA, Martin-Sanchez J' Encinas C, Conde MP, Nieto MJ, Corral M: Prospective evaluation of a transfusion policy of D+ red blood cells into D- patients. Transfusion 2008;48:1318 - 1324.
13. Sachs L: Statistische Methoden, 5th ed. Berlin, Springer, 1978.
14. Schmidt PJ, Morrison EG, Shohh J: The antigenicity of the Rho (Du) blood factor. Blood 1962;20:196 - 202.
15. St-Louis R, et al: DEL blood donors alloimmunised patients: the Canadian experience. Vox Sang 2012;103(suppl 1):14 (abstract 3C-58-03).
16. Perry GH, Xue Y, Smith RS, Meyer WK, Calikan M, Yanez-Cuna 0, Lee AS, Gutiérrez-Arcelus M, Ober C, Hollox EJ, Tyler-Smith C, Lee C: Evolutionary genetics of the human Rh blood group system. Hum Genet 2012;131:1205 - 1216.
17. Kumpel B: Are weak D red blood cells really immunogenic? Transfusion 2006;46:1061 - 1062.
18. Schmidt PT: Are weak D red blood cells really immunogenic? Transfusion 2006;46:2029 - 2030.
19. Gorick B, McDougall DCJ, Ouwehand WH, Overbeeke MAM, Tippett P, Hughes-Tones NC, van Rhenen DJ: Quantitation of D sites on selected 'weak D and 'partial D red cells. Vox Sang 1993;65:136 - 140
20. van Knenen liJ, Uverliee}ce MA, Dudoic de Wit L, Engelfriet CP. Revised definitinn nf the cnncept rhesus-negative blnnd dnnor; practical experiences (in Dutch). Ned Tijdschr Geneeskd 1990;134:1005 - 1007
21. Flegel WA, Khull SR, Wagner FF: Primary anti-D immunization by weak D type 2 RBCs. Transfusion 2uuu4u:428 - 434.
22. Mota M, Fonseca NL Rodrigues A, Kutner TM, Castilho L: Mti-D alloimmunization by weak D type 1 red blood cells with a very low antigen density. Vox Sang 2005;88:130 - 135.
23. Gassner C, Doescher A, Drnovsek TD, Rozman P, Eicher NI, Legler TJ, Lukin S, Garritsen H, Kleinrath T, Egger B, Ehling R, Körmöczi GF, Kilga-Nogler S, Schoenitzer D, Petershofen EK: Presence of RHD in serologically D - , C/E+ individuals: a European multicenter study. Transfusion 2005;45:527 - 538.
24. Wagner T, Körmöczi GF, Buchta C, Vadon M, Lanzer G, Mayr WR, Legler TJ: Mti-D immunization by DEL red blood cells. Transfusion 2005;45:520 - 526.
25. Yasuda H, Ohto H, Sakuma S, Ishikawa Y: Secondary anti-D immunization by Del red blood cells. Transfusion 2005;45:1581 - 1584.
26. Shao CP, Maas JH, Su YQ, Kohler M, Legler TJ: Molecular background of Rh D-positive, D-negative, D(el) and weak D phenotypes in Chinese. Vox Sang 2002;83: 156 - 161.
27. Kim KH, Kim KE, Woo KS, Han JY, Kim TM, Park KU: Primary anti-D immunization by DEL red blood cells. Korean J Lab Med 2009;29:361 - 365.
28. Flegel WA, von Zabern I, Wagner FF: Six years' experience performing RHD genotyping to confirm D - red blood cell units in Germany for preventing antiD immunizations. Transfusion 2009;49:465 - 471.
29. Körmöczi GF, Förstemann E, Gabriel C, Mayr WR, Schonitzer D, Gassner C: Novel weak D types 31 and 32: adsorption-elution-supported D antigen analysis and comparison to prevalent weak D types. Transfusion 2005;45:1574 - 1580.
30. Polin H, Danzer M, Gaszner W, Broda D, St-Louis M, Proll J, Hofer K, Gabriel C: Identification of RHD alleles with the potential of anti-D immunization among seemingly D- blood donors in Upper Austria. Transfusion 2009;49:676 - 681.
31. Wagner FF, Mardt I, Bittner R, DoscherA: Single adsorption /elution with anti-D may be insufficient to determine the D antigen status ofveryweak DEL alleles Transfusion 2012;52(suppl 53):35A (abstract S58-0301).
32. Wagner FF, Fege WA: The RhesusBase Version 2. www.uni-ulm.de/-fwagner/RH/ RB2 jast accessed Apr11 26,2013].
33. LI Q, Ye LY, buo ZH, Qian WI, Znu ZY: Study on the molecular background of Del phenotype in Chinese population (in Chinese). Zhonghua Yi Xue Yi Chuan Xue Za Zhi 2006;23:486 - 491.
34. Muller SP, Bartels I, Stein W, Emons G, Gutensohn K, Kohler M, Legler TJ: The determination of the fetal D status from maternal plasma for decision making on Rh prophylaxis is feasible. Transfusion 2008;48:2292 - 2301.
35. Wagner FF, Mardt I, Bittner R, Doscher A: RHD PCR of blood donors in Northern Germany: use of adsorption /elution to determine D antigen status. Vox Sang 2012;103(suppl 1):15 (abstract 3C-58-04).
36. Singleton BK, Green CA, Kimura K, Minami A, Okubo Y, Daniels GL: Two new RHD mutations associated with the Del phenotype. Transfus Clin Biol 2001;8(suppl 1):9s (abstract).
37. Li Q, Hou L Guo ZH, Ye LY, Yue DQ, Zhu ZY. Molecular basis of the RHD gene in blood donors with DEL phenotypes in Shanghai. Vox Sang 20 099 7: 139 - 146.
38. von Zabern I, Flegel WA: IVSS-38de14 deletion in the RHD gene does not cause a DEL phenotype: relevance for RHD alleles including DFR-3. Transfusion 2007;47:1552 - 1555.
39. Polln H, Danzer M, Hofer K, Gassner W, Gabri& C: Effective m&ecuar RHD typing strategy forbhod donations. Transfusion 2007;47:1350 - 1355.
40. Kim JY, Kim SY, Kim CA, Yon GS, Park SS: Molecular characterization of D - Korean persons: development of a diagnostic strategy. Transfusion 200545:345 - 352.
41. Esteban R, Montero R, Flegel WA, Wagner FF, Subirana L, Parra R, Ribera A,Nogués N: The D category VI type 4 allele is prevalent in the Spanish population. Transfusion 2006;46:616 - 623.
42. Richard M, Perreault J, Constanzo-Yanez J, Khalife 5, St-Louis M: A new DEL variant caused by exon 8 deletion. Transfusion 2007;47:852 - 857.
43. Luettringhaus TA, Cho D, Ryang DW, Flegel WA: An easy RHD genotyping strategy for D - East Asian persons applied to Korean blood donors. Transfusion 2006;46:2128 - 2137.
44. Fichou Y, Chen TM, Le Maréchal C, Jamet D, Dupont I, Chuteau C, Durousseau C, Loirat MJ, Bailly P, Férec C: Weak D caused by a founder deletion in the RHD gene. Transfusion 2012;52:2348 - 2355.
45. Shao CP, Xiong W, Zhou YY. Multiple isoforms excluding normal RhD mRNA detected in Rh blood group Del phenotype with RHD 1227A allele. Transfus Apher Sci 2006;34:145 - 152.
46. Wagner If, FrohmajerA, Ladewig B, Eicher NI, Lonicer CB, Muller TH, Siegel MH, Flegel WA: Weak D alleles express distinct phenotypes. Blood 2000;95: 2699 - 2 708.
47. Christiansen M, Sørensen BS, Grunnet N: RHD positive among C/E+ and D - blood donors in Denmark. Transfusion 2010;50:1460 - 1464.
48. Mota M, Dezan M, Valgueiro MC, Sakashita AM, Kutner TM, Castilho L: RHD allelic identification among D-Brazilian blood donors as a routine test using pools of DNA. J Clin Lab Mal 2012;26:104 - 108.
49. Wagner FF, Ladewig B, Fege WA: The RHCE all&e ceRT: D epitope 6 expression does not require D-specific amino acids. Transfusion 2 003;43:1248 - 1254.
50. Chen Q, Hustinx H, Flegel WA: The RHCE allele ceSL: the second example for D antigen expression without D-specific amino acids. Transfusion 2006;46: 766 - 772.
51. Flegel WA, Wagner FF, Chen Q, Schlanser G, Frame T, Westhoff CM, Moulds MK: The RHCE allele ceCF: the molecular basis of Crawford (RH43). Transfusion 2006;46:1334 - 1342.
52. Cruz BR, Chiba AK, Moritz E, Bordin TO: RHD alleles in Brazilian blood donors with weak D or D-negative phenotypes. Transfus Med 2012;22:84 - 89.
53. Chen Q, Li M, Li M, Lu XS, Lu R, Sun L Liu Z: Molecular basis of weak D and DEL in Han population in Mhui Province, China. Chin Med T (EngI) 2012;125: 3251 - 3255.
54. Londero D, Fiorino M, Miotti V, de Angelis V: Molecular RH blood group typing of serologically D - /CE+ donors: the use of a polymerase chain reaction-sequence-specific primer test kit with pooled samples. Immunohematology 2011;27:25 - 28.
55. Srijinda 5, Suwanasophon C, Visawapoka U, Pongsavee M: RhC phenotyping, adsorption/elution test, and SSP-PCR: the combined test for D-Elute phenotype screening in Thai RhD-negative blood donors. ISRN Hematol 2012;2012:358316.
56. Moussa H, Tsochandaridis M, Chakroun T, Tridi 5, Abdelneji B, Hmida 5, Silvy M, Bailly P, Gabert L Levy-Mozziconacci A, Temni-Yacoub S: Molecular background of D-negative phenotype in the Tunisian population. Transfus Med 2012 22:192 - 198.
57. Reid ME: Transfusion in the age of molecular diagnostics. Hematology Am Soc Hematol Educ Program 2009:171 - 177.
58. Westhoff CM: Molecular genotyping for RHD: what (not) to do? Transfusion 2007;47:1337 - 1339.